Real-time enrollment status for this metastatic thyroid cancer clinical trial
Current Status
Recruiting
Checked: October 3, 2026 at 10:29 PM UTC
| NCT Number | NCT03099356 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Thyroid Cancer |
| Phase | PHASE2 |
| Target Enrollment | 22 participants |
| Active Locations | 1 sites in the US |
| Sponsor | University of Michigan Rogel Cancer Center |
| Last Updated on CT.gov | July 31, 2026 (Jul 31, 2026) |
As of October 3, 2026: Clinical trial NCT03099356 is currently recruiting participants. This phase2 study for metastatic thyroid cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by University of Michigan Rogel Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03099356 is actively recruiting participants as of October 3, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03099356 was last updated Jul 31, 2026 (July 31, 2026). HelloStudys verifies this status automatically.